Research graph
References from Mapping policy architecture for vaccine research, development and manufacturing in Africa: a scoping review protocol. Local targets link to admitted publications; unresolved targets remain external evidence.
More-than-national and less-than-global: The biochemical infrastructure of vaccine manufacturing.
10.1080/03085147.2022.2087899 · 2023 · External reference
Supply and delivery of vaccines for global health.
10.1016/j.coi.2021.03.009 · 2021 · External reference
Designing the global vaccine supply chain: balancing intellectual property rights with post COVID-19 vaccine equity. BMJ Glob.
10.1136/bmjgh-2023-013669 · 2023 · External reference
Precioso AR: Global vaccine supply. The increasing role of manufacturers from middle income countries.
10.1016/j.vaccine.2014.07.069 · 2014 · External reference
Developing Countries Vaccine Manufacturers Network: doing good by making high-quality vaccines affordable for all.
10.1016/j.vaccine.2012.11.060 · 2013 · External reference
The future of epidemic and pandemic vaccines to serve global public health needs.
10.3390/vaccines11030690 · 2023 · External reference
Building global vaccine manufacturing capacity: Spotlight on Africa.
10.1016/j.vaccine.2023.05.009 · 2023 · External reference
Strengthening vaccines and medicines manufacturing capabilities in Africa: challenges and perspectives.
10.15252/emmm.202216287 · 2022 · External reference
Africa-CDC: Partnerships for African Vaccine Manufacturing (PAVM) Framework for Action.
2022 · External reference
Challenges in ensuring global access to COVID-19 vaccines: production, affordability, allocation, and deployment.
10.1016/s0140-6736(21)00306-8 · 2021 · External reference
Building the global vaccine manufacturing capacity needed to respond to pandemics.
10.1016/j.vaccine.2021.02.017 · 2021 · External reference
Scaling up the global COVID-19 vaccination program: production, allocation, and distribution with an emphasis on equity.
2022 · External reference
Vaccine nationalism and internationalism: Perspectives of COVID-19 vaccine trial participants in the United Kingdom.
10.1136/bmjgh-2021-006305 · 2021 · External reference
The tragedy of vaccine nationalism: only cooperation can end the pandemic.
2020 · External reference
Addressing different needs: the challenges faced by India as the largest vaccine manufacturer while conducting the world’s biggest COVID-19 vaccination campaign.
10.3390/epidemiologia2030032 · 2021 · External reference
Expanding global vaccine manufacturing capacity: Strategic prioritization in small countries. PLOS Glob.
10.1371/journal.pgph.0002098 · 2023 · External reference
Vaccine production, distribution, access, and uptake.
10.1016/s0140-6736(11)60478-9 · 2011 · External reference
Vaccine manufacturing: challenges and solutions.
10.1038/nbt1261 · 2006 · External reference
Reforming the health sector in developing countries: the central role of policy analysis.
10.1093/heapol/9.4.353 · 1994 · External reference
A landscape analysis of the vaccine ecosystem in Africa: research and development funding, clinical trials, regulation, and manufacturing readiness. Lancet Glob.
10.1016/s2214-109x(25)00314-6 · 2025 · External reference
Scoping studies: towards a methodological framework.
10.1080/1364557032000119616 · 2005 · External reference
Updated methodological guidance for the conduct of scoping reviews.
10.11124/jbies-20-00167 · 2020 · External reference
PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation.
10.7326/m18-0850 · 2018 · External reference
Scoping review protocol: Search strategy, data extraction instrument and PRISMA-ScR checklist.
10.6084/m9.figshare.31949979.v1 · 2026 · External reference
Assessing the Readiness of Local Vaccine Manufacturing in African Countries: Protocol for a Scoping Review.
10.2196/81231 · External reference
10.3389/frhs.2026.1678143 · Admitted local publication
